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5′-NucleotidaseExtracellular adenosine 5′-triphosphate (ATP) acts as a proinﬂammatory mediator. Adenosine, the ﬁnal prod-
uct of ATP breakdown, is an anti-inﬂammatory compound, acting mainly on adenosine A2A receptors. Consid-
ering that the kidney is an organ strongly affected during systemic inﬂammatory responses and that
ectonucleotidases are responsible for the control of extracellular nucleotide and nucleoside levels, we exam-
ined the endotoxin-induced effects on ectonucleotidases in kidney membranes of mice, and whether CGS-
21680 hydrochloride (3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]
purin-2-yl]amino]ethyl]phenyl]propanoic acid), a selective adenosine A2A receptor agonist, antagonizes the
lipopolysaccharide (LPS)-induced effects on nucleotide catabolism in kidney. Animals were injected intraper-
itoneally with 12 mg/kg LPS and/or 0.5 mg/kg CGS-21680 or saline. Nucleotidase activities were determined
in kidney membrane preparations and ATP metabolism was measured by high performance liquid chroma-
tography (HPLC) assay. Analysis of ectonucleotidase expression was carried out by semi-quantitative semi-
quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Exposure to endotoxemia
promoted an increase in ATP and p-Nitrophenyl thymidine 5′-monophosphate (p-Nph-5′-TMP) hydrolysis,
and a decrease in adenosine 5′-monophosphate (AMP) hydrolysis. CGS-21680 treatment failed to reverse
these changes. HPLC analysis indicated a decrease in extracellular ATP and adenosine levels in groups treated
with LPS and LPS plus CGS-21680. The expression pattern of ectonucleotidases revealed an increase in
Entpd3, Enpp2, and Enpp3 mRNA levels after LPS injection. These ﬁndings indicate that nucleotide and nucle-
oside availability in mouse kidney is altered at different stages of endotoxemia, in order to protect the integ-
rity of this organ when exposed to systemic inﬂammation.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Inﬂammation is an adaptive response to injurious stimuli, such as
infection and tissue damage (Medzhitov, 2008). Depending on the
trigger, the inﬂammatory response has a different physiological pur-
pose and pathological consequences. Microbial lipopolysaccharide
(LPS), a component of the outer membrane of Gram-negative bacte-
ria, activates Toll-like receptor 4 (TLR4) to induce an inﬂammatory
response (Akira et al., 2001; Alving, 1993). There is evidence that
sepsis and septic shock are the most important causes of severe
acute kidney injury (AKI) in critically ill patients and correspond toquímica e Psicofarmacologia,
ade de Biociências, Pontifícia
ranga, 6681, Caixa Postal 1429,
58; fax: +55 51 3320 3568.
evier OA license.50% or more of cases of AKI in Intensive Care Units (Hoste et al.,
2006; Silvester et al., 2001).
Extracellular nucleotides and nucleosides play important roles dur-
ing the inﬂammatory process. Extracellular adenosine 5′-triphosphate
(ATP) functions as a proinﬂammatory and immunostimulatory media-
tor in the microenvironment of damaged cells (Bours et al., 2006).
ATP activates members of the P2 receptor family, comprising P2Y G-
protein coupled receptors and P2X receptors, which are ligand-gated
ion channels (Ralevic and Burnstock, 1998). Adenosine, the ﬁnal prod-
uct of ATP breakdown, is a signaling molecule and adenosine receptors
are recognized as importantmolecular transducers in the pathophysiol-
ogy of inﬂammation (Blackburn et al., 2009). Adenosine interacts with
members of the P1 receptor family, which consists of four G-protein-
coupled receptor subtypes (A1, A2A, A2B, and A3 receptors) (Fredholm
et al., 2001; Klotz, 2000). Activation of these receptors leads to numer-
ous anti-inﬂammatory events, including inhibition of T-cell activation
(Erdmann et al., 2005; Huang et al., 1997) and limiting the production
of inﬂammatory mediators, such as Interleukin (IL) 12, Tumor necrosis
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Lappas et al., 2005).
Extracellular nucleotide and nucleoside levels are controlled
through the action of ectonucleotidases. This group of ectoenzymes
is composed of the ecto-nucleoside triphosphate diphosphohydrolase
(E-NTPDase) family, the ecto-pyrophosphatase/phosphodiesterase
(E-NPP) family and ecto-5′-nucleotidase (EC 3.1.3.5) (Zimmermann,
2001). Eight different ENTPD genes encode members of the E-NTPDase
protein family, with four of the E-NTPDases (E-NTPDase1, 2, 3, and 8)
being expressed as cell surface-located enzymes (Bigonnesse et al.,
2004; Zimmermann, 2001). The E-NPP family consists of seven
structurally-related ectoenzymes; however, only E-NPP1-3 have the
ability to hydrolyze nucleotides and is relevant in the context of the
purinergic signaling cascade (Goding et al., 2003; Yegutkin, 2008).
Ecto-5′-nucleotidase is the enzyme responsible for adenosine 5′-
monophosphate (AMP) hydrolysis, generating the nucleoside adeno-
sine (Zimmermann, 1996), and it has also been proposed to have non-
enzymatic functions, such as induction of intracellular signaling and
mediation of cell–cell and cell–matrix adhesions (Airas et al., 1997;
Resta et al., 1998).
Considering that the kidney is an organ strongly affected during
systemic inﬂammatory responses and that ectonucleotidases are re-
sponsible for the control of extracellular nucleotide and nucleoside
levels, which play an important role in inﬂammatory events, we ex-
amined the effects of endotoxemia on ectonucleotidase activities,
ATP metabolism and mRNA gene expression of these ecto-enzymes
in kidney membranes of mice. The effect of CGS-21680 hydrochloride
(3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-
oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid), a selective
adenosineA2A receptor agonist, on nucleotide catabolism in kidneymem-
branes was also investigated.2. Materials and methods
2.1. Chemicals
CGS-21680, LPS from Escherichia coli, serotype 0111:B4, Coomas-
sie Blue, nucleotides, Malachite Green, Trizma Base, HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid), EDTA (ethylenedia-
minetetraacetic acid) and p-Nitrophenyl thymidine 5′-monophosphate
(p-Nph-5′-TMP) were obtained from Sigma-Aldrich (St. Louis, MO,
USA). Trizol® Reagent, Deoxyribonucleotide Triphosphates (dNTPs),
oligonucleotides, Taq polymerase, Low DNA Mass Ladder, and
SuperScript™ III First-Strand Synthesis SuperMix were purchased
from Invitrogen (Carlsbad, CA, USA). Primers were obtained from
Integrated DNA Technologies (Coralville, IA, USA) and GelRed™ was
purchased from Biotium (Hayward, CA, USA). All reagents used were
of analytical grade.2.2. Animals
In all experiments, male F1 mice (approximately 8–10 weeks old,
weighing around 50 g) from Fundação Estadual de Produção e
Pesquisa em Saúde (FEPPS, Porto Alegre, RS, Brazil) were used and
housed four to a cage, with water and food ad libitum. The animal
house was kept on a 12 h light/dark cycle (lights on at 7:00 am) at a
temperature of 23±1 °C. Procedures for the care and use of animals
were adopted according to the guidelines of the Colégio Brasileiro
de Experimentação Animal (COBEA), based on the Guide for the
Care and Use of Laboratory Animals (National Research Council) and
all efforts were made to minimize the number of animals used in
this study and their suffering. This study was approved by the Ethics
Committee of Universidade Federal do Rio Grande do Sul (UFRGS)
under license number 2006628.2.3. Experimental protocols
The animals received intraperitoneal (i.p.) injections of saline
(0.9%), LPS (12 mg/kg) (Pawlinski et al., 2003), and CGS-21680
(0.5 mg/kg body weight) (Martire et al., 2007), according to the
groups described below. All solutions were administered in a volume
of 2 μL/kg body weight. Mice were randomly divided in: (i) control
group (SAL), which received a single injection of saline, (ii) CGS-
21680 group (CGS-21680), which received a single injection of CGS-
21680, (iii) LPS group (LPS 24 h), which was subjected to endotoxe-
mia by a single injection of LPS, and (iv) LPS plus CGS-21680 (LPS+
CGS-21680 24 h), which was subjected to endotoxemia by a single in-
jection of LPS and received a single injection of CGS-21680 immedi-
ately after. In order to evaluate the effect of CGS-21680 when the
endotoxemia had already become established, the following groups
were analyzed: (v) LPS group (LPS 48 h), which was subjected to
endotoxemia by a single injection of LPS and 24 h later received a sin-
gle injection of saline, and (vi) LPS plus CGS-21680 (LPS+ CGS-21680
48 h), which was subjected to endotoxemia by a single injection of
LPS and 24 h later received a single injection of CGS-21680. All ani-
mals were euthanized by decapitation 24 h after the last injection.
2.4. Preparation of kidney membranes
Kidney membranes were prepared essentially as previously de-
scribed by Nagy and Delgado-Escueta (1984), with minor modiﬁca-
tions. Brieﬂy, about 1.0 g of both right and left kidneys was
dissected on ice, washed, and gently homogenized in 10 volumes of
a medium containing 0.32 M sucrose, 0.1 mM EDTA and 5.0 mM
HEPES, pH 7.5 (Medium I), before being centrifuged at 1000 g for
10 min. The supernatant was collected and centrifuged again at
12000 g for 20 min. The resulting supernatant was discarded and
the pellet was resuspended in 1.2 mL of Medium I. An aliquot of
1.0 mL of the crude mitochondrial fraction was mixed with 4.0 mL
of 8.5% Percoll solution and layered onto an isoosmotic discontinuous
Percoll/sucrose gradient (10%/16%). After centrifugation at 15000 g
for 20 min, the fractions that banded at the 10%/16% Percoll interface
were collected with a wide-tip disposable plastic transfer pipette. The
kidney membrane fraction was washed twice with Medium I by
centrifugation at 15000 g for 20 min to remove the contaminating
Percoll. The pellet resulting from this second centrifugation was
then resuspended to a ﬁnal concentration of 0.5–0.8 mg/mL. The
membranes were prepared fresh daily and maintained at 0–4 °C
throughout the experimental procedure.
2.5. Protein determination
Protein was measured by the Coomassie Blue method using bo-
vine serum albumin as standard (Bradford, 1976).
2.6. Assays of ecto-nucleoside triphosphate diphosphohydrolase
(E-NTPDase) and ecto-5′-nucleotidase activities
For the measurement of ATP hydrolysis in membrane fractions,
the reaction mixture employed contained 45 mM Tris–HCl, 5.0 mM
KCl, 0.1 mM EDTA, 10 mM glucose, 225 mM sucrose, 1.5 mM CaCl2,
0.1 mM sodium azide, and 2.0 μg/mL oligomycin, pH 7.5, in a ﬁnal vol-
ume of 200 μL. The adenosine 5′-diphosphate (ADP) hydrolysis was
assessed using the same reaction mixture described above, except
for the fact that 1.0 mM CaCl2 was included and neither sodium
azide nor oligomycin were employed in these assays. The activity of
ecto-5′-nucleotidase was determined in a reaction medium contain-
ing 100 mM Tris–HCl, 1.0 mM MgSO4, pH 7.5, in a ﬁnal volume of
200 μL. About 13 μg of kidney membrane protein was added to each
tube and these were preincubated for 10 min at 37 °C. The enzyme re-
actions were started by the addition of nucleotides as substrates in a
Table 1
PCR primers sequences.
Enzyme Sequence (5′-3′)
Entpd1 Sense GGT GGC GTC CTT AAG GAC CCG TGC
Entpd1 Antisense GGA GCT GTC TGT GAA GTT ATA GCC TTG CAG
Entpd2 Sense CCA CTG TCA GCC TGT CAG GGA CCA GC
Entpd2 Antisense CGA CAG CCG TGT CTG CCG CCT TC
Entpd3 Sense ACC GCC TTC ACC TTG GGC CAT G
Entpd3 Antisense GCT GAG AAG CAG TAG GAC CGG GCA TAC
Enpp1 Sense TAT TGG CTA TGG ACC TGC CTT CAA GC
Enpp1 Antisense GTA GAA TCC GGG GCC TCC CGT AG
Enpp2 Sense GCG ATC TCC TAG GCT TGA AGC CAG C
Enpp2 Antisense GCT CTG GGA TGC TAG AGA CCT CAG CCT G
Enpp3 Sense ACA TGC AGG AGA GTT GTC AAC CCC TGC
Enpp3 Antisense AGA ACA GTG TAT GAA CTC CAC ATG GGC ATC
Nt5e Sense CCA TCA CCT GGG AGA ACC TGG CTG C
Nt5e Antisense CTT GAT CCG CCC TTC AAC GGC TG
Actb Sense GTG CTA TGT TGC TCT AGA CTT CGA GCA GG
Actb Antisense CAC CGA TCC ACA CAG AGT ACT TGC GCT C
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10 min of incubation, trichloroacetic acid (TCA) (5%, ﬁnal concentra-
tion) was added to stop the reactions. Incubation times, protein con-
centrations, reaction mixtures, and substrate concentrations were
chosen according to previous studies (Fürstenau et al., 2010; Vieira
et al., 2001). The amount of inorganic phosphate (Pi) released was de-
termined using a colorimetric method as previously described by
Chan et al. (1986). Controls to correct for non-enzymatic substrate
hydrolysis were performed by adding membrane fractions after the
reactions had been stopped with TCA. All reactions were performed
in triplicate. Enzyme activities were generally expressed as nmol Pi
released per min per milligram of protein.
2.7. Assay of ecto-nucleotide pyrophosphatase/phosphodiesterase
(E-NPP) activity
The phosphodiesterase activity was assessed using p-Nph-5′-TMP,
an artiﬁcial substrate. Brieﬂy, for the assay of kidney membrane E-
NPP activity, the reaction medium containing 50 mM Tris–HCl buffer,
5.0 mM KCl, 0.1 mM EDTA, 10 mM glucose, 225 mM sucrose, and
1.5 mM CaCl2, pH 8.9, was preincubated with approximately 13 μg
per tube of kidney membrane protein for 10 min at 37 °C in a ﬁnal
volume of 200 μL. The enzyme reaction was started by the addition
of p-Nph-5′-TMP to a ﬁnal concentration of 0.5 mM. After 10 min of
incubation, 200 μL of 0.2 N sodium hydroxide (NaOH) was added to
the medium to stop the reaction. Incubation time and protein concen-
tration were chosen in order to ensure the linearity of the reaction.
The amount of p-nitrophenol released from the substrate was mea-
sured at 400 nm using a molar extinction coefﬁcient of 18.8×10−3/
M/cm. Controls to correct for non-enzymatic substrate hydrolysis
were performed by adding kidney membrane preparations after the
reaction had been stopped with NaOH. All reactions were performed
in triplicate. Enzyme activity was generally expressed as nmol p-
nitrophenol released per min per milligram of protein (Fürstenau et
al., 2010; Sakura et al., 1998).
2.8. Analysis of ATP metabolism by high performance liquid chromatog-
raphy (HPLC)
Kidney membranes from all groups tested were obtained as previ-
ously described. The same reaction mixture and protein concentra-
tion were used to analyze the metabolism of ATP. However, the
enzymatic reactions were started by the addition of 0.1 mM ATP
(ﬁnal concentration) in a ﬁnal volume of 200 μL at 37 °C. Aliquots of
the samples were collected at different times of incubation (0, 3, 10,
30 and 60 min) with the reactions being stopped on ice. All samples
were centrifuged at 14000 g for 15 min. Aliquots of 40 μL were ap-
plied to a reversed-phase HPLC system using a 25 cm C18 Shimadzu
column (Shimadzu, Japan) at 260 nm with a mobile phase containing
KH2PO4 and 5.0 mM tetrabutylammonium chloride, pH 6.0, in 30%
methanol as previously described by Voelter et al. (1980). The peaks
of purines (ATP, ADP, AMP, and adenosine) were identiﬁed by their
retention times and quantiﬁed by comparison with standards. Results
are expressed as nmoles of the different compounds per 200 μL of
reaction mixture for each time of incubation. All incubations were
carried out in triplicate and the controls to correct for non-enzymatic
hydrolysis of nucleotides were performed by measuring the peaks
present for the same reaction medium without membranes.
2.9. Analysis of gene expression by semiquantitative reverse
transcriptase-polymerase chain reaction (RT-PCR)
Analysis of NTPDase1 (Entpd1), 2 (Entpd2), 3 (Entpd3),
8 (Entpd8), NPP1 (Enpp1), 2 (Enpp2), 3 (Enpp3), and 5′-nucleotidase
(Nt5e) gene expression was carried out by a RT-PCR assay. Twenty-
four and/or 48 h after treatments, both right and left kidneys ofmice (n=3 for each group) were removed for total RNA extraction
with the Trizol® Reagent in accordance with the manufacturer's in-
structions. RNA purity was determined spectrophotometrically and
assessed by electrophoresis in a 1.0% agarose gel using GelRed™.
The cDNA species were synthesized using SuperScript™ III First-
Strand Synthesis SuperMix from 3 μg of total RNA following the sup-
plier's instructions. For PCR assays, 1 μL of cDNA was used as a tem-
plate and screened with speciﬁc primers for Entpd1, 2, 3, 8, Enpp1,
2, 3, and Nt5e. PCR was carried out in a volume of 25 μL using a con-
centration of 0.2 μM of each primer, 200 μMMgCl2, and 1 U Taq poly-
merase. The cycling conditions for all PCRs were as follows: Initial
1 min denaturation step at 94 °C, 1 min at 94 °C, 1 min annealing
step (Entpd1, 2, Enpp1 and Actb: 63 °C; Entpd3, Enpp3, Nt5e,:
62 °C; Entpd8: 64 °C; Enpp2: 61 °C), 1 min extension step at 72 °C.
These steps were repeated for 35 cycles. Finally, a 10 min extension
step was performed at 72 °C. Primer sequences as well as the ampliﬁ-
cation products are listed in Table 1. Ten microliters of the PCR reac-
tion mixture was analyzed on a 1% agarose gel using GelRed™ and
photographed under UV light. The Low DNA Mass Ladder was used
as a molecular marker and normalized employing Actb (β-actin) as
a constitutive gene. The images of stained PCR products were ana-
lyzed by optical densitometry and semi-quantiﬁed (enzyme/Actb
mRNA ratios) using the computer software Image J.
2.10. Statistical analysis
Results are expressed as means±standard error (S.E.M.). Statisti-
cal analysis was performed by one-way analysis of variance (ANOVA),
followed by a Tukeymultiple range test. Statistically signiﬁcant differ-
ences between groups were considered for a Pb0.05.
3. Results
3.1. Effect of CGS-21680 and modeled endotoxemia on ectonucleotidase
activities in kidney membranes
After 48 h of LPS exposure we observed a signiﬁcant increase in
ATP hydrolysis (48%; Pb0.05) when compared with the control
group. When we administered CGS-21680 24 h after LPS exposure
(LPS+ CGS-21680 48 h) there was a trend towards an increase in
ATP hydrolysis, but it was not signiﬁcant when compared with the
control group. In the groups that received LPS and LPS plus CGS-
21680 and were analyzed 24 h later, we did not ﬁnd any signiﬁcant
difference when compared to the control (Fig. 1A). Fig. 1B shows
ADP hydrolysis after endotoxemia induction and CGS-21680 expo-
sure; there was no signiﬁcant difference between the treated groups
and the control groups.
Fig. 1. ATP (A) and ADP (B) hydrolysis in kidney membrane preparations from mice 24
and 48 h after endotoxemia induction and CGS-21680 treatment. The data represent
mean±S.E.M. (n=5 at least). Statistical analyses were performed by one-way analysis
of variance (ANOVA), followed by a Tukey multiple range test, considering Pb0.05 as
signiﬁcant (*). Mice were divided in: (i) control group (SAL), which received a single
injection of saline, (ii) CGS-21680 group (CGS-21680), which received a single injec-
tion of CGS-21680, (iii) LPS group (LPS 24 h), which was given a single injection of
LPS, (iv) LPS plus CGS-21680 (LPS+ CGS-21680 24 h), which was given a single injec-
tion of LPS and received a single injection of CGS-21680 immediately after, (v) LPS
group (LPS 48 h), which was given a single injection of LPS and 24 h later received a
single injection of saline, and (vi) LPS plus CGS-21680 (LPS+ CGS-21680 48 h),
which was given a single injection of LPS and 24 h later received a single injection of
CGS-21680.
Fig. 2. ρ-Nph-5′-TMP hydrolysis in kidney membrane preparations from mice 24 and
48 h after endotoxemia induction and CGS-21680 treatment. The data represent
means±S.E.M. (n=5 at least). Statistical analyses were performed by one-way analy-
sis of variance (ANOVA), followed by a Tukey multiple range test, considering Pb0.05
as signiﬁcant (*). Mice were divided in: (i) control group (SAL), which received a single
injection of saline, (ii) CGS-21680 group (CGS-21680), which received a single injec-
tion of CGS-21680, (iii) LPS group (LPS 24 h), which was given a single injection of
LPS, (iv) LPS plus CGS-21680 (LPS+ CGS-21680 24 h), which was given a single injec-
tion of LPS and received a single injection of CGS-21680 immediately after, (v) LPS
group (LPS 48 h), which was given a single injection of LPS and 24 h later received a
single injection of saline, and (vi) LPS plus CGS-21680 (LPS+ CGS-21680 48 h),
which was given a single injection of LPS and 24 h later received a single injection of
CGS-21680.
Fig. 3. AMP hydrolysis in kidney membrane preparations from mice 24 and 48 h after
endotoxemia induction and CGS-21680 treatment. The data represent means±S.E.M.
(n=5 at least). Statistical analyses were performed by one-way analysis of variance
(ANOVA), followed by a Tukey multiple range test, considering Pb0.05 as signiﬁcant
(*). Mice were divided in: (i) control group (SAL), which received a single injection
of saline, (ii) CGS-21680 group (CGS-21680), which received a single injection of
CGS-21680, (iii) LPS group (LPS 24 h), which was given a single injection of LPS, (iv)
LPS plus CGS-21680 (LPS+ CGS-21680 24 h), which was given a single injection
of LPS and received a single injection of CGS-21680 immediately after, (v) LPS
group (LPS 48 h), which was given a single injection of LPS and 24 h later received
a single injection of saline, and (vi) LPS plus CGS-21680 (LPS+ CGS-21680 48 h),
which was given a single injection of LPS and 24 h later received a single injection
of CGS-21680.
425F.C. Vuaden et al. / European Journal of Pharmacology 674 (2012) 422–429The hydrolysis of the artiﬁcial substrate, ρ-Nph-5′-TMP, used to
determine E-NPP activities, was signiﬁcantly increased after LPS ex-
posure in LPS 48 h (47%; Pb0.05) and LPS plus CGS-21680 48 h
(51%; Pb0.05) groups when compared to the saline-control group.
This increase was not observed in LPS 24 h and LPS plus CGS-21680
24 h groups (Fig. 2).
For AMP hydrolysis, we observed a signiﬁcant decrease in the LPS
24 h group (40%; Pb0.05) and with LPS and CGS-21680 co-
administration (37%; Pb0.05), when compared to the control group.
In the LPS 48 h and LPS plus CGS-21680 48 h groups there were no
signiﬁcant differences in AMP hydrolysis when compared with con-
trol (Fig. 3). When we injected CGS-21680 alone, it did not alter enzy-
matic activities for any of the nucleotidases tested compared to saline.
3.2. Metabolism of ATP in kidney membranes of mice exposed to LPS and
CGS-21680
The ATP metabolism in the kidney membrane preparations from
control and treated groups was measured by HPLC and is presented
in Fig. 4. The results show that all treated groups presented a decrease
in extracellular ATP levels. In Fig. 4E and F, it can be seen that for AMP,
between 3 and 30 min of incubation, LPS 24 h, LPS 48 h, and LPS plus
CGS-21680 48 h groups exhibited an accumulation in extracellularlevels of this nucleotide. After 10 min of incubation, this accumulation
was more apparent in LPS 24 h and LPS 48 h groups (Fig. 4C and E).
The extracellular levels of adenosine were decreased in LPS 24 h, LPS
plus CGS-21680 24 h, LPS 48 h, and LPS plus CGS-21680 48 h groups
when compared to the control in the initial points (3 and 10 min).
Fig. 4. Metabolism of ATP and product formation in kidney membrane preparations from mice 24 and 48 h after endotoxemia induction and CGS-21680 treatment. Kidney mem-
branes were incubated with 0.1 mM of ATP. The data represent mean±S.E.M. (n=3 at least) for (A) control group (SAL), which received a single injection of saline, (B) CGS-21680
group (CGS-21680), which received a single injection of CGS-21680, (C) LPS group (LPS 24 h), which was given a single injection of LPS, (D) LPS plus CGS-21680 (LPS+ CGS-21680
24 h), which was given a single injection of LPS and received a single injection of CGS-21680 immediately after, (E) LPS group (LPS 48 h), which was given a single injection of LPS
and 24 h later received a single injection of saline, and (F) LPS plus CGS-21680 (LPS+ CGS-21680 48 h), which was given a single injection of LPS and 24 h later received a single
injection of CGS-21680. ADO = adenosine.
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kidney
The gene expression patterns of ectonucleotidases after CGS-
21680 and LPS treatment were examined and the results showed
that 48 h of modeled endotoxemia promoted an increase in Entpd3,
Enpp2, and Enpp3 transcript levels. Likewise, the groups that received
LPS plus CGS-21680 injection and were subjected to 48 h of endotox-
emia (LPS+ CGS-21680 48 h) exhibited an increase in the expression
of Entpd3, Enpp2, and Enpp3 (Fig. 5). For Nt5e, we did not observe
any changes in the levels of mRNA transcripts for the groups tested
(data not shown).
4. Discussion
The involvement of extracellular ATP in inﬂammation has been
known since the 1970s and 1980s (Cockcroft and Gomperts, 1980;
Dahlquist and Diamant, 1970). This molecule appears to be an“endogenous signal” and exhibits chemotactic and activating effects
on leukocytes, which represents potent immuno-enhancing activity
(Oppenheim and Yang, 2005). ATP induces the production of inﬂam-
matory cytokines, such as IL-1β, IL-2, IL-12, IL-18 and TNFα, via acti-
vation of P2X7 receptors, and several pieces of work have
demonstrated the participation of ATP in the inﬂammatory process,
acting via this purinoceptor subtype (Elliott and Higgins, 2004;
Labasi et al., 2002; Le Feuvre et al., 2002; Solle et al., 2001). Accep-
tance of the idea that extracellular ATP participates in inﬂammation
increased after P2 receptors were cloned and their expression in in-
ﬂammatory cells was completely characterized (Di Virgilio et al.,
2009). P2 receptors are expressed in the kidney where they are
found mainly in the glomeruli and tubules (Bailey et al., 2004;
Unwin et al., 2003). Therefore, in the present study, we observed
that LPS-induced endotoxemia increased the nucleotide hydrolysis
due to E-NTPDase, E-NPP and ecto-5′-nucleotidase activities in kid-
ney membrane preparations from mice, as well as the mRNA tran-
script levels of these ecto-enzymes.
Fig. 5. Gene expression patterns of Entpd3, Enpp2, Enpp3, and Actb in mouse kidney.
Total RNA was isolated and subjected to RT-PCR for the indicated targets. Three inde-
pendent experiments were performed, with entirely consistent results. Statistical ana-
lyses were performed by one-way analysis of variance (ANOVA), followed by a Tukey
multiple range test, considering Pb0.05 as signiﬁcant (*) difference to control group.
Mice were divided in: (i) control group (SAL), which received a single injection of sa-
line, (ii) CGS-21680 group (CGS-21680), which received a single injection of CGS-
21680, (iii) LPS group (LPS 24 h), which was given a single injection of LPS, (iv) LPS
plus CGS-21680 (LPS+ CGS-21680 24 h), which was given a single injection of LPS
and received a single injection of CGS-21680 immediately after, (v) LPS group
(LPS 48 h), which was given a single injection of LPS and 24 h later received a single in-
jection of saline, and (vi) LPS plus CGS-21680 (LPS+ CGS-21680 48 h), which was
given a single injection of LPS and 24 h later received a single injection of CGS-21680.
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ectonucleotidases (E-NTPDase family, E-NPP family and 5′-nucleotid-
ase) (Zimmermann, 2001). In our results, we observed a signiﬁcant
increase in ATP hydrolysis in kidney membrane preparations after
mice had been subjected to 48 h of endotoxemia. For ADP hydrolysis,
there was a trend towards an increase in the same group, but it was
not statistically signiﬁcant. As observed for ATP, the hydrolysis of p-
Nph-5′-TMP, an artiﬁcial substrate used to determine NPP activity,
was also signiﬁcantly increased after this time of LPS exposure.
These results could be related to a compensatory response 48 h
after LPS injection, leading to a decrease in ATP availability, and there-
fore reducing its proinﬂammatory inﬂuence. Similar results for ATP
and ADP hydrolysis were observed by our group when we tested
whether LPS injection was able to alter nucleotidase activities in rat
lymphocytes from mesenteric lymph nodes (Vuaden et al., 2007).
On the other hand, we observed a different pattern of variation for
AMP hydrolysis in kidney membrane preparations. We found a signif-
icant decrease in AMP hydrolysis 24 h after LPS injection and there
was no difference in AMP hydrolysis 48 h after LPS injection com-
pared to the control group. It is possible that AMP hydrolysis 48 h
after LPS injection returned to control values due to thestoichiometric effect of the increase in hydrolysis of the other nucle-
otides. Furthermore, the efﬁcient removal of these nucleotides re-
duces the ATP/ADP feed-forward inhibition of ecto-5′-nucleotidase,
which could allow a burst-like formation of adenosine (Cunha, 2001).
In a similar way to ATP, adenosine can also be considered a molec-
ular danger signal because its extracellular levels rise markedly in re-
sponse to tissue damage. However, by contrast with ATP, elevated
extracellular adenosine levels mediate an autoregulatory immuno-
suppressive loop to protect healthy tissues (Bours et al., 2006). The
four members of the P1 receptor family are all G-protein coupled.
A1 and A3 receptors are coupled to a Go/Gi protein, causing inhibition
of adenylyl cyclase and, consequently, decreasing the production of
cAMP (Akbar et al., 1994; Palmer et al., 1995). Conversely, A2A and
A2B receptors are coupled to Gs protein, with ligand-binding leading
to stimulation of adenylyl cyclase and, in turn, increasing cAMP levels
(Olah, 1997; Pierce et al., 1992). A role for adenosine in the control of
inﬂammation has been suggested due to its anti-inﬂammatory prop-
erties, acting mainly on A2A receptors (Capecchi et al., 2005; Sullivan,
2003; Thiel et al., 2003). A2A receptors have taken center stage as the
primary anti-inﬂammatory effectors of extracellular adenosine and
have been considered to play a non-redundant role in down-
regulating cell-mediated immunity and, also, in activating pro-
resolution pathways (Bours et al., 2006; Haskó and Pacher, 2008).
A2A receptors in the kidney have been detected in the renal microvas-
culature (Okusa, 2002), as well as on mesangial (Scholz-Pedretti et
al., 2001) and tubular epithelial cells (Lee and Emala, 2002). For this
reason, we tested whether CGS-21680, a selective agonist of the
adenosine A2A receptor, differently modulates ectonucleotidase ac-
tivities in kidney membrane preparations from endotoxemic mice.
CGS-21680 was administered in two different ways, either concomi-
tant with LPS or 24 h after LPS injection. The changes observed in nu-
cleotide hydrolysis in kidney membrane preparations of mice during
modeled endotoxemia were not reversed by CGS-21680 administered
concomitantly with LPS, differently for other studies from our group,
when we demonstrated that CGS-21680 co-administered with LPS
was able to prevent the LPS-induced increase in ATP, AMP, and ρ-
Nph-5′-TMP hydrolysis (Vuaden et al., 2011). However, when CGS-
21680 was administered 24 h after LPS injection, we observed that
the increase in ATP hydrolysis 48 h after LPS exposure was less pro-
nounced if animals were treated with CGS-21680, suggesting that
when the LPS-induced inﬂammatory process has been already estab-
lished, CGS-21680 was more effective to reverse ATP hydrolysis to
control levels. In contrast, for other nucleotide analysis, when LPS
was administered 24 h before CGS-21680, this compound failed to re-
verse the effect of LPS. Since it has been reported that E-NTPDases
present different abilities to hydrolyze nucleotides tri and diphos-
phates (Zimmermann, 2001), we cannot exclude the possibility that
LPS might up-regulate the ectonucleotidase activities and that the ad-
ministration of CGS-21680 could reverse the LPS-induced effect over
distinct E-NTPDase members.
Here we report that LPS administration induces changes in ecto-
nucleotidase activities in kidney membrane preparations from mice.
The decreased AMP hydrolysis after 24 h of modeled endotoxemia
leads us to suggest that, in the initial phase of the inﬂammatory pro-
cess, the production of extracellular adenosine via AMP in the kidney
was diminished. However, the ATP and p-Nph-5′-TMP hydrolysis in-
creased when this process was more established (48 h after LPS injec-
tion), indicating that the supply of extracellular ATP is reduced. The
analysis of purine metabolism performed by HPLC corroborates this
hypothesis, since we observed that ATP levels were markedly de-
creased in treated groups when compared to control groups. It has
been demonstrated that during septic events a possible explanation
for the loss of glomerular ﬁltration rate is that although the glomeru-
lus displays both afferent and efferent arteriolar vasodilatation, the
efferent vasodilatation is higher (Bellomo et al., 2008). Since adeno-
sine is a vasodilator (Kitakase et al., 1991) and ATP acts as a
428 F.C. Vuaden et al. / European Journal of Pharmacology 674 (2012) 422–429proinﬂammatory agent (Pelegrin et al., 2008), our results lead us to
speculate that there is a reduction in adenosine and ATP availability
in kidney during inﬂammatory events in order to protect this organ
from the deleterious effects of these molecules.
Purinoceptor and ectonucleotidase expression in immune cells
changes under inﬂammatory conditions, allowing for the progressive
acquisition of an immunomodulatory purinergic repertoire by the
cells involved in inﬂammatory and immune responses. The ecto-
enzymes ENTPDase1 and ecto-5′-nucleotidase (also identiﬁed as
CD39 and CD73, respectively) control extracellular nucleotide levels
and thus regulate the extent of purinergic signaling (Bours et al.,
2006). In order to determine whether the modeled endotoxemia
and CGS-21680 could alter ectonucleotidase gene expression, we per-
formed RT-PCR assays. The levels of mRNA transcripts for Entpd3,
Enpp2, and Enpp3 were increased after 48 h of LPS exposure, and
when CGS-21680 was administered 24 h after LPS. In contrast, we
did not observe any changes in Nt5e mRNA levels for the groups test-
ed. For the levels of other enzyme mRNA transcripts analyzed, the dif-
ferences between treated groups and the control group were not so
evident. However, gene expression is regulated by various factors in-
volving cell machinery and signal transduction pathways and enzyme
activity cannot be directly correlated with the gene expression pat-
tern or with protein levels due to the existence of several post-
translational events (Nedeljkovic et al., 2005). One possible reason
for the changes observed in the other ecto-enzymes is the control
exerted by phosphorylation, since ectonucleotidases present poten-
tial phosphorylation sites on extracellular domains (Bigonnesse et
al., 2004; Lavoie et al., 2004).
5. Conclusion
In summary, our results indicate a change in nucleotide and nucleo-
side viability in the kidneys ofmice at different times after endotoxemia
induction, in order to protect the integrity of this organ when exposed
to inﬂammation.
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